Related Experiment Video
Updated: Jan 2, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Intramitochondrial Src kinase links mitochondrial dysfunctions and aggressiveness of breast cancer cells
Marie-Ange Djeungoue-Petga1,2, Olivier Lurette1,2, Stéphanie Jean1,2
1Canada Research Chair in Mitochondrial Signaling and Physiopathology, Moncton, NB, Canada.
Abstract:
High levels and activity of Src kinase are common among breast cancer subtypes, and several inhibitors of the kinase are currently tested in clinical trials. Alterations in mitochondrial activity is also observed among the different types of breast cancer. Src kinase is localized in several subcellular compartments, including mitochondria where it targets several proteins to modulate the activity of the organelle. Although the subcellular localization of other oncogenes modulates the potency of known treatments, nothing is known about the specific role of intra-mitochondrial Src (mtSrc) in breast cancer. The aim of this work was to determine whether mtSrc kinase has specific impact on breast cancer cells. We first observed that activity of mtSrc is higher in breast cancer cells of the triple negative subtype. Over-expression of Src specifically targeted to mitochondria reduced mtDNA levels, mitochondrial membrane potential and cellular respiration. These alterations of mitochondrial functions led to lower cellular viability, shorter cell cycle and increased invasive capacity. Proteomic analyses revealed that mtSrc targets the mitochondrial single-stranded DNA-binding protein, a regulator of mtDNA replication. Our findings suggest that mtSrc promotes aggressiveness of breast cancer cells via phosphorylation of mitochondrial single-stranded DNA-binding protein leading to reduced mtDNA levels and mitochondrial activity. This study highlights the importance of considering the subcellular localization of Src kinase in the development of potent therapy for breast cancer.
Insights
Mitochondrial Src (mtSrc) kinase activity is elevated in triple-negative breast cancer, driving cancer aggressiveness by impairing mitochondrial function and DNA replication. Targeting mtSrc may offer novel therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Mitochondrial Biology
Background:
- Src kinase is frequently overexpressed in breast cancer, and its inhibition is a therapeutic target.
- Mitochondrial dysfunction is implicated in various cancer types.
- The specific role of mitochondrial Src (mtSrc) in breast cancer remains largely unexplored.
Purpose of the Study:
- To investigate the specific impact of mtSrc on breast cancer cell behavior.
- To determine if mtSrc activity differs across breast cancer subtypes.
- To elucidate the molecular mechanisms by which mtSrc influences mitochondrial function and cancer progression.
Main Methods:
- Comparative analysis of mtSrc activity in different breast cancer subtypes.
- Experimental manipulation of mtSrc expression in breast cancer cells.
- Assessment of mitochondrial parameters including mtDNA levels, membrane potential, and respiration.
- Proteomic analysis to identify mtSrc targets within mitochondria.
Main Results:
- mtSrc activity was significantly higher in triple-negative breast cancer cells.
- Overexpression of mtSrc led to decreased mtDNA levels, reduced mitochondrial membrane potential, and impaired cellular respiration.
- These mitochondrial alterations correlated with decreased cellular viability, a shorter cell cycle, and increased invasive capacity.
- Proteomic analysis identified the mitochondrial single-stranded DNA-binding protein as a key target of mtSrc.
Conclusions:
- mtSrc plays a critical role in promoting breast cancer aggressiveness, particularly in the triple-negative subtype.
- mtSrc promotes aggressiveness through phosphorylation of the mitochondrial single-stranded DNA-binding protein, leading to reduced mtDNA levels and mitochondrial dysfunction.
- The subcellular localization of Src kinase, specifically within mitochondria, is a crucial factor in breast cancer progression and warrants consideration for therapeutic development.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Destabilization of Microtubules

